Publication | Open Access

Iberdomide (CC-220) is a potent cereblon E3 ligase modulator with antitumor and immunostimulatory activities in lenalidomide- and pomalidomide-resistant multiple myeloma cells with dysregulated CRBN

Hematological MalignancyDysregulated CrbnImmunostimulatory ActivitiesImmunologyHematologyImmune Checkpoint InhibitorImmunotherapyMedicineRadiation OncologyNovel TherapyHealth Sciences